Speech and Language Therapy After Stroke
- Conditions
- Ischemic Stroke
- Interventions
- Behavioral: Imitate Therapy
- First Posted Date
- 2008-07-11
- Last Posted Date
- 2013-06-11
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 34
- Registration Number
- NCT00713050
- Locations
- 🇺🇸
Solodkin/Small Brain Circuits Laboratory, Irvine, California, United States
🇺🇸University of California Irvine, Irvine, California, United States
Study of Rapamycin Plus Ketoconazole in Advanced Cancers
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2014-01-17
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 57
- Registration Number
- NCT00708591
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2017-01-04
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 68
- Registration Number
- NCT00708773
- Locations
- 🇺🇸
NorthShore University HealthSystem, Evanston, Illinois, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
Rapamycin in Advanced Cancers
- First Posted Date
- 2008-06-30
- Last Posted Date
- 2014-01-17
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 40
- Registration Number
- NCT00707135
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Metabolic Study of Sleep Apnea in Men and Women
- Conditions
- Obstructive Sleep Apnea (OSA)
- Interventions
- Device: CPAP
- First Posted Date
- 2008-06-27
- Last Posted Date
- 2020-03-24
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 27
- Registration Number
- NCT00706511
- Locations
- 🇺🇸
University of Chicago Department of Medicine, Section of Endocrinology, Diabetes & Metabolism, Chicago, Illinois, United States
Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea
- Conditions
- Polycystic Ovary SyndromeObstructive Sleep Apnea
- Interventions
- Drug: Depot Lupron followed by estrogen plus placebo
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 18
- Registration Number
- NCT00696111
- Locations
- 🇺🇸
University of Chicago Department of Medicine, Section of Endocrinology, Diabetes & Metabolism, Chicago, Illinois, United States
Repeated High-dose Inhaled Corticosteroids for Asthma
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- University of Chicago
- Registration Number
- NCT00695604
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Evaluation of Lovastatin in Severe Persistent Asthma
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2013-06-21
- Lead Sponsor
- University of Chicago
- Registration Number
- NCT00689806
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
- Conditions
- Acute Myelogenous LeukemiaLymphoid LeukemiaChronic Myelogenous LeukemiaMalignant LymphomaHodgkin's DiseaseChronic Lymphocytic LeukemiaMyeloproliferative DisorderAnemia, AplasticMyelodysplastic Syndromes
- Interventions
- First Posted Date
- 2008-05-23
- Last Posted Date
- 2016-11-22
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 204
- Registration Number
- NCT00683046
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Rapamycin Plus Bevacizumab in Advanced Cancers
- Conditions
- Advanced CancerMetastatic Cancer
- Interventions
- First Posted Date
- 2008-04-28
- Last Posted Date
- 2014-01-17
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 28
- Registration Number
- NCT00667485
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States